Switzerland: Duomed enhances offering in Switzerland with acquisition of REY Médical
Belgium-based European medtech distributor, Duomed, has acquired REY Médical, a leading distributor of medical devices, based in Geneva, Switzerland.
Founded in 2003, REY Médical is...
France: Ramsay Santé launches Amend & Extend debt refinancing process
Leading private hospitalisation and primary care provider in Europe, Ramsay Santé, the 52.79% owned subsidiary of ASX-listed Ramsay Health Care, has launched a €1.65bn...
Switzerland: CordenPharma announces investment to grow its Peptide technology platform
CordenPharma, a full-service CDMO, has announced its largest strategic investment to date with a committed spend of circa €900m (US$981m) over the next three...
The Netherlands: Aedifica sells portfolio of three care homes
Belgium-listed specialist healthcare REIT Aedifica has completed the disposal of a portfolio of three care residences in the Netherlands for a total of €31.5m...
Germany: CatalYm closes oversubscribed Series D financing
Germany-based biotech company, CatalYm, has closed an oversubscribed US$150m Series D financing. Founded in 2016 with support from Forbion and BGV, CatalYm is a...
France: Afflelou prepares €560m bond issue and launches tender offer
Afflelou is issuing €560m (US$610m) Senior Secured Notes due 2029. Founded in Bordeaux in 1972 by Alain Afflelou, the group is one of Europe’s...
Switzerland: Asceneuron announces US$100m Series C
Asceneuron, a clinical stage biotech company, has announced a US$100m oversubscribed Series C financing to advance the clinical development of its clinical pipeline of...
Denmark: Duke Street to acquire Agito Medical from Philips
European mid-market private equity group, Duke Street, has agreed to acquire Agito Medical from Philips. Agito is a medical imaging solutions provider supporting healthcare...
Portugal: Biovance Capital Partners announces first close of new biotech fund
Portugal-based Biovance Capital Partners, a life sciences venture capital firm, has announced the first close of its new biotech fund, Biovance Capital Fund I,...
Italy: Rossini prices €1.85bn two-part high yield bond
Rossini, the Luxembourg-based holding company that directly owns 51.8% of Italy-based listed pharmaceutical company Recordati, has priced €1.85bn (US$2.01bn) senior secured notes, consisting of...
Advertisement
